- Q3 2024 Medexus Pharmaceuticals Inc Earnings Call TranscriptFeb 08, 2024C$1.92 (-28.89%)Earnings
- Q2 2024 Medexus Pharmaceuticals Inc Earnings Call TranscriptNov 09, 2023C$2 (-2.44%)Earnings
- Medexus Pharmaceuticals Inc Annual Shareholders Meeting TranscriptSep 21, 2023
- Medexus Pharmaceuticals Inc at Openexchange Share Series (Virtual) TranscriptAug 14, 2023
- Q1 2024 Medexus Pharmaceuticals Inc Earnings Call TranscriptAug 10, 2023C$2.92 (-0.34%)Earnings
- Q4 2023 Medexus Pharmaceuticals Inc Earnings Call TranscriptJun 22, 2023C$1.4 (+12.90%)Earnings
- Medexus Pharmaceuticals Inc at Bloom Burton & Co Healthcare Investor Conference TranscriptApr 25, 2023
- Q3 2023 Medexus Pharmaceuticals Inc Earnings Call TranscriptFeb 09, 2023C$1.8 (-1.10%)Earnings
- Q2 2023 Medexus Pharmaceuticals Inc Earnings Call TranscriptNov 09, 2022C$1.78 (-26.45%)Earnings
- Medexus Pharmaceuticals Inc Investor Update Call TranscriptSep 21, 2022
- Medexus Pharmaceuticals Inc Annual Shareholders Meeting TranscriptSep 15, 2022
- Q1 2023 Medexus Pharmaceuticals Inc Earnings Call TranscriptAug 09, 2022C$2.95 (+18.00%)Earnings
- Q4 2022 Medexus Pharmaceuticals Inc Earnings Call TranscriptJun 23, 2022C$1.95 (-9.30%)Earnings
- Medexus Pharmaceuticals Inc to Discuss Treosulfan Data TranscriptJun 06, 2022
- Q3 2022 Medexus Pharmaceuticals Inc Earnings Call TranscriptFeb 10, 2022C$3.27 (+5.48%)Earnings
- Medexus Pharmaceuticals Inc at Issuer Direct Winter Wonderland Best Ideas Investor Conference (Virtual) TranscriptFeb 08, 2022
- Medexus Pharmaceuticals Inc at SNN Network Canada Virtual Event TranscriptDec 08, 2021
- Medexus Pharmaceuticals Inc at Benzinga Global Small Cap Conference (Virtual) TranscriptOct 28, 2021
- Medexus Pharmaceuticals Inc at SNN Network Summer Event (Virtual) TranscriptAug 19, 2021
Q1 2023 Medexus Pharmaceuticals Inc Earnings Call Transcript
Good day, ladies and gentlemen, and welcome to the Medexus Pharmaceuticals First Quarter 2023 Earnings Call. (Operator Instructions).
It is now my pleasure to turn the floor over to your host, Victoria Rutherford, Investor Relations at Medexus Pharmaceuticals. Ma'am, the floor is yours.
Thank you, and good morning, everyone. Welcome to the Medexus Pharmaceuticals First Fiscal Quarter 2023 Earnings Call. On the call this morning are Ken d'Entremont, Chief Executive Officer; and Marcel Konrad, Chief Financial Officer. If you have any questions after the conference call or would like further information about the company please contact Adelaide Capital at (480) 625-5772.
I would like to remind everyone that this discussion will include forward-looking information as defined in securities laws. Actual results may differ materially from historical results or results anticipated by the forward-looking information. In addition, this discussion will also include non-GAAP measures, such as adjusted net loss and adjusted EBITDA, which do
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)